Blog

Sensus Healthcare (NASDAQ:SRTS), a medical device maker specializing in non-invasive dermatology treatments, reported its second-quarter earnings on August 7, 2025. The headline news was a

Century Aluminum (NASDAQ:CENX), a top producer of primary aluminum with operations in the U.S. and Iceland, released its second quarter results on August 7, 2025. The biggest news: GAAP revenue for

Xponential Fitness (NYSE:XPOF), a leading curator of boutique fitness brands operating through an asset-light franchise model, reported results for the second quarter of 2025 on August 7. The main

Arcellx (NASDAQ:ACLX), a biotechnology company developing cell therapies for blood cancers and autoimmune diseases, reported its second quarter 2025 results on August 7, 2025. The most notable

Shares of cooler company Yeti (NYSE: YETI) tumbled to close Thursday down 10.4% after the company reported mixed earnings this morning.

Heading into the report, analysts forecast Yeti would earn

loanDepot (NYSE:LDI), a major U.S. non-bank mortgage lender, reported earnings for the second quarter of fiscal 2025 on August 7, 2025. The company's results showed a rise in loan originations, but

OneStream (NASDAQ:OS), a software provider focused on modernizing finance through unified platforms for the office of the CFO, reported results for Q2 2025 on August 7, 2025. The company delivered

Intel (NASDAQ: INTC) shares fell 3.14% Tuesday to close at $19.77, underperforming the broader chip sector despite a generally upbeat day for tech stocks. Trading volume surged to 130.1 million

Golden Entertainment (NASDAQ:GDEN), an operator of casinos, hotel rooms, and taverns concentrated in Nevada, released its second quarter 2025 results on August 7, 2025. The main news from the

Dianthus Therapeutics (NASDAQ:DNTH), a clinical-stage biotech developing therapies for autoimmune neuromuscular diseases, reported second quarter results on August 7, 2025. Net loss per share (GAAP)

Fox Factory (NASDAQ:FOXF), a maker of premium suspension systems for bikes, powersports, and vehicles, reported its second quarter fiscal 2025 earnings on August 7, 2025. The most important news

Iovance Biotherapeutics (NASDAQ:IOVA), a biotechnology company specializing in cell therapies for solid tumors, reported GAAP earnings on August 7, 2025. The standout news was a 93% year-over-year

Janux Therapeutics (NASDAQ:JANX), a clinical-stage biotechnology company focused on developing next-generation immunotherapies, reported second quarter results on August 7, 2025. The main headline

Fidus Investment Corporation (NASDAQ:FDUS), a business development company focused on financing lower middle-market companies, released its Q2 2025 earnings results on August 7, 2025. The company

SenesTech (NASDAQ:SNES), a biotechnology company specializing in non-lethal fertility control solutions for rodents, announced its Q2 fiscal 2025 earnings on August 7, 2025. The company reported

Cidara Therapeutics (NASDAQ:CDTX), a biotechnology company focused on the development of innovative therapies for infectious diseases and oncology, released its second-quarter 2025 earnings on

Yelp (NYSE:YELP), an online platform connecting consumers with local businesses through reviews and advertising, reported its Q2 2025 results on August 7, 2025. The most notable news was that the

Rani Therapeutics (NASDAQ:RANI), a biotech company developing oral biologic drug delivery technology, released its earnings for the second quarter of fiscal 2025 on August 7, 2025. Marking an

Nerdy (NYSE:NRDY), the online learning platform behind Varsity Tutors, released its second quarter results on August 7, 2025. The earnings report showed total GAAP revenue of $45.3 million, slightly

Alpha Teknova (NASDAQ:TKNO), a specialist in custom bioprocess solutions for the life sciences sector, released its results on August 7, 2025. The most important news: Revenue (GAAP) rose by 7%

Dorchester Minerals (NASDAQ:DMLP), a Dallas-based owner of oil and natural gas mineral and royalty interests, reported sharply lower results. Released on August 7, 2025, the earnings revealed a

Inseego (NASDAQ:INSG), a wireless networking provider focused on 5G and fixed wireless access technology, announced its results for the fiscal second quarter ended June 30, 2025, on Aug. 7, 2025

Skye Bioscience (NASDAQ:SKYE), a biotechnology company developing novel obesity therapeutics, released its second quarter earnings on August 7, 2025. As in prior quarters, no commercial revenue was

IN8bio (NASDAQ:INAB), a clinical-stage biotechnology company focused on developing gamma-delta T cell therapies for cancer and autoimmune diseases, released its second quarter results on August 7

System1 (NYSE:SST), a digital marketing and technology company focused on privacy-centric search, couponing, and online mapping products, released its earnings for the second quarter of fiscal 2025